Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-02 Sale |
2021-12-06 7:28 pm |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
8,113 | $5.68 | $46,082 | 140,261 (Indirect) |
View |
| 2021-12-02 Sale |
2021-12-06 7:27 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
8,113 | $5.68 | $46,082 | 140,261 (Indirect) |
View |
| 2021-11-29 Sale |
2021-12-01 6:31 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
72,418 | $6.5648 | $475,406 | 140,513 (Indirect) |
View |
| 2021-11-29 Sale |
2021-12-01 6:31 pm |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
72,418 | $6.5648 | $475,406 | 140,513 (Indirect) |
View |
| 2021-11-23 Sale |
2021-11-26 4:44 pm |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
56,425 | $7.3371 | $413,996 | 142,759 (Indirect) |
View |
| 2021-11-23 Sale |
2021-11-26 4:43 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
56,425 | $7.3371 | $413,996 | 142,759 (Indirect) |
View |
| 2021-11-18 Sale |
2021-11-22 7:13 pm |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
50,169 | $8.1206 | $407,404 | 144,508 (Indirect) |
View |
| 2021-11-18 Sale |
2021-11-22 7:12 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
50,169 | $8.1206 | $407,404 | 144,508 (Indirect) |
View |
| 2021-11-15 Sale |
2021-11-17 7:56 pm |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
23,625 | $9.3766 | $221,523 | 146,063 (Indirect) |
View |
| 2021-11-15 Sale |
2021-11-17 7:55 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
23,625 | $9.3766 | $221,523 | 146,063 (Indirect) |
View |
| 2021-11-09 Sale |
2021-11-12 5:53 pm |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
86,802 | $10.56 | $917,006 | 146,794 (Indirect) |
View |
| 2021-11-09 Sale |
2021-11-12 5:52 pm |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
86,802 | $10.56 | $917,006 | 146,794 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-20 Option Award |
2022-01-24 8:05 pm |
N/A 2032-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | Patel Premal Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 8:04 pm |
N/A 2032-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive |
520,674 | $0 | 520,674 (Direct) |
View |
| 2021-10-06 Option Award(A) |
2021-12-17 4:31 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-12-17 4:30 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Abingworth LLP 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2021-11-01 Option Award |
2021-11-02 7:10 pm |
N/A 2031-10-31 |
eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:22 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:20 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Bhatt Elizabeth Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:18 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:16 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:12 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Lasky Laurence Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:10 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2021-09-07 5:04 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Column Group II GP LP Svennilson Peter COLUMN GROUP II LP GOEDDEL DAVID V 10% Owner |
0 | $0 | 4,309,329 (Indirect) |
View |
Ownership |
2021-09-02 3:26 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | SR ONE CAPITAL MANAGEMENT LLC SR ONE CAPITAL PARTNERS I LP SR One Capital Fund I Aggregator LP SR One Co-Invest I LLC SR One Co-Invest I Manager LLC George Simeon 10% Owner |
0 | $0 | 7,427,452 (Indirect) |
View |
| 2021-08-25 Conversion |
2021-08-27 6:53 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
143,202 | $0 | 144,236 (Indirect) |
View |
Ownership |
2021-08-27 6:51 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M 10% Owner |
0 | $0 | 5,427,452 (Indirect) |
View |
| 2021-08-25 Option Award |
2021-08-27 6:50 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
4,714,667 | $0 | 754,824 (Indirect) |
View |
| 2021-08-25 Option Award |
2021-08-27 6:50 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | ROOT JONATHAN D Director 10% Owner |
712,785 | $10 | 754,824 (Indirect) |
View |
| 2021-08-25 Conversion |
2021-08-27 6:43 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Bhatt Elizabeth Director |
9,047 | $0 | 17,500 (Indirect) |
View |
| 2021-08-25 Option Award |
2021-08-27 6:39 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director 10% Owner |
5,427,452 | $0 | 5,427,452 (Indirect) |
View |
Ownership |
2021-08-27 6:31 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Abingworth LLP 10% Owner |
0 | $0 | 5,427,452 (Indirect) |
View |
| 2021-08-25 Conversion |
2021-08-27 6:31 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Locust Walk Sponsor LLC 10% Owner |
3,511,250 | $0 | 7,567,500 (Direct) |
View |
| 2021-08-25 Option Award |
2021-08-27 6:26 pm |
N/A 2028-03-26 |
eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director |
27,698 | $0 | 51,840 (Direct) |
View |
| 2021-08-25 Option Award |
2021-08-27 6:19 pm |
N/A 2030-07-28 |
eFFECTOR Therapeutics Inc. | EFTR | Patel Premal Chief Medical Officer |
487,504 | $0 | 487,504 (Direct) |
View |